Bicara Therapeutics Inc
Bicara Therapeutics Inc (BCAX) Historical Volatility
BCAX's 30 day historical volatility is 190.18%, in the 100th percentile of readings over the past year. This is a high percentile, meaning Bicara Therapeutics Inc shares have swung far more than usual. BCAX's 30 day implied volatility sits at 128.93%, with an IV Rank of 81.35%, leaving IV 61.25 points below historical volatility. This means options are pricing in less movement than the stock has actually delivered, as of Nov 13, 2026.
Read more
Tracking BCAX historical volatility helps you see how much Bicara Therapeutics Inc's stock price has actually moved, giving you a baseline for whether option premiums look fair, cheap, or expensive. While implied volatility shows what the market expects, BCAX's HV, also known as realized volatility, shows what actually happened. Use our scanner to monitor BCAX 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.
Historical volatility is the annualized standard deviation of a stock's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. BCAX's 30 day historical volatility, or BCAX HV, is one of the most widely watched readings because it balances responsiveness with stability. Comparing BCAX's HV to its implied volatility reveals the volatility risk premium. When IV sits well above HV, options are pricing in more movement than the stock has actually delivered, giving option sellers an edge. When HV runs hot relative to IV, options are pricing in less movement than the stock has delivered, and buyers may be underpaying for it.
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-b) for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts. Bicara Therapeutics Inc. is a subsidiary of Biocon Limited.
Historical Volatility
Historical movement is elevated versus the past year. The stock has been unusually active.
As of Nov 13, 2026
As of Nov 13, 2026
As of Nov 13, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →